Ashland Inc.
ASH- Exchange
- NYSE
- Industry
- Wholesale-Chemicals & Allied Products
- SEC CIK
- 0001674862
No open-market purchases or sales by Ashland Inc. insiders were filed in the last 90 days; 358 institutions reported holding it in 13F filings for Q2 2026, worth $3.44B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:55 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $845.0M (46.3% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 4, 2025 | Nov 6, 2024 | Nov 1, 2023 | Nov 7, 2022 | Nov 9, 2021 |
| Revenue | $1.82B | $2.11B | $2.19B | $2.39B | $2.11B |
| Cost of revenue | $1.27B | $1.50B | $1.52B | $1.56B | $1.44B |
| Gross profit | $549.0M | $618.0M | $668.0M | $830.0M | $670.0M |
| Research and development | $54.0M | $55.0M | $51.0M | $55.0M | $50.0M |
| Selling, general and administrative | $344.0M | $404.0M | $365.0M | $393.0M | $358.0M |
| Operating income | -$775.0M | -$26.0M | $172.0M | $333.0M | $181.0M |
| Interest expense | $61.0M | $53.0M | $54.0M | $62.0M | $69.0M |
| Income tax | $13.0M | -$223.0M | -$8.00M | $25.0M | -$38.0M |
| Net income | -$845.0M | $169.0M | $178.0M | $927.0M | $220.0M |
| EPS, basic | $-18.23 | $3.40 | $3.36 | $16.71 | $3.63 |
| EPS, diluted | $-18.23 | $3.36 | $3.31 | $16.41 | $3.59 |
| Weighted shares, basic | 46.0M | 49.0M | 53.0M | 55.0M | 60.0M |
| Weighted shares, diluted | 46.0M | 50.0M | 54.0M | 56.0M | 61.0M |
| Margins and growth | |||||
| Gross margin | 30.1% | 29.2% | 30.5% | 34.7% | 31.7% |
| Operating margin | -42.5% | -1.2% | 7.9% | 13.9% | 8.6% |
| Net margin | -46.3% | 8.0% | 8.1% | 38.8% | 10.4% |
| Revenue growth, year over year | −13.7% | −3.6% | −8.4% | +13.3% | −9.2% |
| Net income growth, year over year | −600.0% | −5.1% | −80.8% | +321.4% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 4, 2025 | Nov 6, 2024 | Nov 1, 2023 | Nov 7, 2022 | Nov 9, 2021 |
| Cash and equivalents | $215.0M | $300.0M | $417.0M | $646.0M | $210.0M |
| Accounts receivable | $242.0M | $243.0M | $338.0M | $402.0M | $369.0M |
| Inventory | $568.0M | $545.0M | $626.0M | $629.0M | $473.0M |
| Total current assets | $1.21B | $1.20B | $1.51B | $1.77B | $1.72B |
| Property, plant and equipment | $1.20B | $1.30B | $1.37B | $1.34B | $1.43B |
| Goodwill | $705.0M | $1.38B | $1.36B | $1.31B | $1.43B |
| Intangible assets | $563.0M | $751.0M | $886.0M | $963.0M | $1.10B |
| Total assets | $4.61B | $5.64B | $5.94B | $6.21B | $6.61B |
| Accounts payable | $189.0M | $214.0M | $210.0M | $265.0M | $236.0M |
| Short-term debt | – | $0 | $16.0M | $0 | $365.0M |
| Total current liabilities | $423.0M | $490.0M | $456.0M | $553.0M | $934.0M |
| Long-term debt | $1.38B | $1.35B | $1.31B | $1.27B | $1.60B |
| Shareholders' equity | $1.90B | $2.87B | $3.10B | $3.22B | $2.75B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 4, 2025 | Nov 6, 2024 | Nov 1, 2023 | Nov 7, 2022 | Nov 9, 2021 |
| Capital expenditures | $98.0M | $137.0M | $170.0M | $113.0M | $105.0M |
| Depreciation and amortization | $237.0M | $274.0M | $243.0M | $241.0M | $244.0M |
| Stock-based compensation | $14.0M | $15.0M | $22.0M | $18.0M | $15.0M |
| Dividends paid | $76.0M | $78.0M | $76.0M | $70.0M | $70.0M |
| Share buybacks | $100.0M | $380.0M | $300.0M | $200.0M | $450.0M |
| Investing cash flow | -$3.00M | – | – | – | – |
| Financing cash flow | -$179.0M | -$479.0M | -$371.0M | -$896.0M | -$426.0M |
| Net change in cash | -$85.0M | -$117.0M | -$229.0M | $436.0M | -$244.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.8% | 0.7% | 1.0% | 0.8% | 0.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.